Market Place
Sourcing Support
GSK completes acquisition of Affinivax, Inc.
16 Aug 2022 //
PHARMIWEB
Affinivax`s Data for Protection Against Serotype 3 in Pneumococcal Vaccine
21 Jun 2022 //
BUSINESSWIRE
GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster
31 May 2022 //
REUTERS
Affinivax to Highlight PC Data from COVID-19 MAPS Vaccine Development Program
02 May 2022 //
BUSINESSWIRE
Affinivax Reacquires Rights from Astellas for ASP3772 from MAPS Platform
01 Mar 2022 //
BUSINESSWIRE
Affinivax Appoints Rick Malley as CSO
22 Dec 2021 //
BUSINESSWIRE
CEPI and Affinivax Partner to Advance the Development of a Novel Covid-19
13 Dec 2021 //
CONTRACTPHARMA
CEPI Partners with Affinivax to Develop Novel COVID-19 Vaccine
13 Dec 2021 //
BUSINESSWIRE
Affinivax Appoints Kara Bickham, MD, as Chief Medical Officer
09 Aug 2021 //
BUSINESSWIRE
Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
14 Jul 2021 //
PHARMATIMES
Affinivax and Astellas Present Safety and Immunogenicity Data of ASP3772
12 Jul 2021 //
BUSINESSWIRE
Affinivax receives $22m funding for development of Staphylococcus aureus vaccine
09 Mar 2021 //
PHARMAFILE
Affinivax Announces $226 M Series C to Advance Its Pipeline of Novel MAPS™
08 Jan 2021 //
BUSINESSWIRE
Affinivax nabs huge $226M funding round
08 Jan 2021 //
FIERCEBIOTECH
Affinivax Announces the Presentation of Phase 1 Clinical Data for its MAPS™
21 Oct 2020 //
BIOSPACE
Affinivax Announces the Presentation of Ph1 Clinical Data for its MAPS™ Vaccine
21 Oct 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.